Abstract Body

Background: The ERAMUNE01 trial showed that a year of MVC+RAL intensification alone or with 3 IL7 injections in treated chronic HIV+ patients did not decrease cell associated HIV DNA. IL7 induced a strong transient CD4 T cells increase affecting mainly the CM subset. To further understand the effects of IL7 we evaluated distribution and characteristics of viral reservoir among the distinct resting CD4 T cell subsets. Methodology: We sorted resting CD25-69-DR-CD4+ N, CM, TM and EM T subsets at D0 and W56 from RAL+MVC and RAL+MVC+IL7 arms (6+6 pts). In each sorted sample: 1) HIV DNA was quantified per 10 6 subset cells, reported to absolute subset count and analysed for subset contribution to total HIV reservoir, using nonparametric tests; 2) HIV inducibility was tested in vitro with or without IL7 or antiCD3+CD28+IL2+IL7 D0 stimulation, amounts of HIV RNA released in supernatants being normalized for HIV DNA content 3) Transcriptome was analysed using the human genome wide microarray Platform 4) Unspliced HIV RNA transcripts from total CD4 were detected using qPCR (GAG gene). Results: At D0 reservoir distribution did not significantly differ among sorted resting CD4 subsets despite a higher contribution of CM than EM in RAL+MVC+IL7 (p 0.01). At W56 cell HIV DNA did not change in any RAL+MVC subset. At W56 RAL+MVC+IL7 CM reservoir did not significantly increase though CM delta raw (HIV DNA/10 6 CM p 0.02), absolute values (HIV DNA/CM/mL p 0.008) and fold changes (W56-D0/D0 p 0.04) from baseline increased more than in RAL+MVC. Instead RAL+MVC+IL7 TM HIV DNA raw and absolute values increased at W56 (p 0.03) and when compared to RAL+MVC (p 0.01). Thus the RAL+MVC+IL7 reservoir became skewed towards an increase in TM compared to N as raw values (p 0.02) and an increase in CM and TM compared to EM as absolute values (p 0.04). IL7 alone induced HIV production in vitro from both arms (5/8 CM and 7/8 TM tested subsets); antiCD3+CD28+IL2+IL7 stimulation induced HIV in all tested sorted sample (N, CM, TM, EM at D0 and CM at W56). Ex vivo analysis of HIV RNA transcripts showed no IL7 effect 2 to 46 weeks after IL7 infusions. Similarly no transcriptome changes were observed in any resting CD4 T cell subsets between D0 and W56 in both arms. Conclusions: A year long strategy combining a cycle of IL7 injections plus MVC+RAL intensification did not show major changes in HIV reservoir among resting CD4 T subsets (except an increase in TM cells with intermediate lifespan) despite IL7 ability to trigger HIV production in vitro, to expand “early” (CM) memory and to decrease more differentiated and senescent T cells. A year after IL7 cycle, distribution of reservoir remains however skewed towards TM with a reduced contribution of short-lived EM cells, suggesting those changes do not simply reflect homeostatic proliferation effects of IL7.